Navam Capital has announced the final close of its maiden fund at over ₹315 crore, after exercising its green-shoe option on a base target of ₹250 crore.
The India-focused deep-tech investor has raised capital from a mix of technology founders, business operators, industrial groups, conglomerates and prominent family offices.
The Kolkata-based firm’s portfolio already includes the likes of Ather Energy, GalaxEye, Morphing Machines, Unbox Robotics and Vyome Therapeutics.
“India today offers a rare convergence of world-class engineering talent, deepening capital markets and cost-efficient R&D. This trifecta is expanding the opportunity set of ventures being created and built,” said Rajeev Mantri, founder & managing partner at Navam Capital.
Mantri is also the co-founder of Vyome Therapeutics.
Navam said it works closely with founders to help translate lab-scale breakthroughs into manufacturable, commercially viable products, drawing on its network of industrial and B2B partners.
“The evolution of India’s entrepreneurial landscape has been extremely promising, and we are in the early stages of a long runway ahead for product-driven and IP-differentiated venture building,” said Dr. Anjan Ray, investment partner at Navam Capital.
The firm now intends to deepen its engagement with IP-led ventures as it looks to create an ‘innovation premium’ for globally competitive deep-tech products built from India.
Leave a Reply